Several studies demonstrated that unlike normal cells, RAD52 is required for the survival of cancer cells with loss-of-function mutation in genes such as BRCA1, BRCA2, PALB2, and RAD51 paralogs (184–186). This evidence concerns the gene BRCA1 and cancer.